Investor Relations

VBL Therapeutics to Report First Quarter 2020 Financial Results on May 14

May 04, 2020

TEL AVIV, Israel, May 04, 2020 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced that it will host a conference call and live audio webcast on Thursday, May 14, 2020 at 8:30am Eastern Time to report first quarter ended March 31, 2020 financial results and to provide a corporate update.

 
Thursday May 14th @ 8:30amET
From the US:    877-407-9208
International:   201-493-6784
Israel:    1 809 406 247
Conference ID:   13703295
Webcast:   https://edge.media-server.com/mmc/p/ubiyng5a
     


About VBL

Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for areas of unmet need in cancer and immune/inflammatory indications.

INVESTOR CONTACT:
Michael Rice
LifeSci Advisors, LLC
(646) 597-6979

VBL Logo.jpg

Source: VBL Therapeutics